Table 4.
Cell Line Used | Toxin Levels | Exposure Time and Route | Conclusions | Observations | Comment | References |
HepaRG | DON 0.2–10 µM ZEN 1.5–75 µM |
48 h | Synergistic at 48 h cell viability | Cell viability | Doses correspond to IC50 values after 48 h | [105] |
DON 7.35 µM ZEN 55.1 µM |
18 h | Additive at 18 h cell mortality | Cell mortality | |||
HepaRG | DON 2.5 µM ZEN 0.24 µM |
14 days 28 days 42 days |
Additive | Cell viability | Doses correspond to maximum levels permitted in cereals for humans | [106] |
HepaRG | DON 0.2 µM ZEN 20 µM |
1 and 24 h | Synergistic at 1 h Antagonistic at 24 h |
Cell proteome | Doses correspond to IC10 values after 48 h | [107] |
BEL-7402 | DON 0.37–16.9 µM ZEN 0.31–31.4 µM |
24 h | Additive | Cell viability | Mixtures used DON + ZEN 0.37 + 0.31 µM 0.68 + 0.63 µM 1.69 + 1.57 µM 3.7 + 3.1 µM 6.8 + 15.7 µM 16.9 + 31.4 µM |
[108] |
HepG2 | DON 0.34–67.5 µM ZEN 15.7–157 µM |
24 h | Synergistic | Cell viability | Mixtures used DON + ZEN 0.034 + 15.7 µM 1.69 + 47.1 µM 3.7 + 62.8 µM 37 + 126 µM 67.5 + 157 µM |
[109] |
HepG2 | DON 0.02–2 µM ZEN 0.28–34.5 µM |
48 h | Synergistic | Cell viability | DON + ZEN 0.02 + 0.28 µM 0.03 + 0.53 µM 0.07 + 1.1 µM 0.14 + 3 µM 0.27 + 4.4 µM 0.51 + 8.6 µM 1 + 17.3 µM 2 + 34.5 µM |
[110] |
RAW 246.7 | DON 0.0027–0.34 µM ZEN 0.28–37.69 µM |
48 h | Synergistic | Cell viability | DON + ZEN 0.0027 + 0.28 µM 0.0054 + 0.6 µM 0.01 + 1.19 µM 0.02 + 2.36 µM 0.04 + 4.71 µM 0.08 + 9.42 µM 0.17 + 18.8 µM 0.34 + 37.69 µM |
[110] |
Caco-2 | DON 3.3–16.7 µM ZEN 10–50 µM | 24 h | Antagonistic | Cell viability | DON and ZEN combination in 1:3 ratio | [112] |
HCT116 | DON 100 µM ZEN 40 µM |
24 h | Antagonistic | Cytotoxicity, mitochondrial apoptosis | Doses correspond to IC30 values after 24 h | [113] |
48 h | Cell cycle analysis | |||||
IPEC-J2 | Cytotoxic concentration DON 2 µM DON ZEN 40 µM |
48 h | Cytotoxic concentration Reported as non-additive | Cell viability | Dose correspond to cytotoxic and non-cytotoxic concentrations | [90] |
Non-cytotoxic concentration DON 0.5 µM ZEN 10 µM |
Non-cytotoxic concentration Synergistic | |||||
PK15 | DON 0.25 µM ZEN 20 µM | 24 h | Synergistic | ROS levels Apoptosis |
Doses used are concentrations close to IC10 concentration which were 0.157 and 27.583 µM for DON and ZEN, respectively | [114] |
Porcine splenic lymphocytes | DON + ZEN 0.2 + 0.25 µM 1 + 1.26 µM 5.1 + 6.28 µM |
48 h | Synergistic | Apoptosis Oxidative injury |
[115] | |
Porcine lymphocytes | DON + ZEN 0.24 + 15.7 μM 0.71 + 31.4 μM |
24/48/72 h | Antagonistic | Cell viability | Doses used were below IC50 concentration after 24, 48, 72 h exposure | [116] |
Antagonistic at lower concentration Synergistic at 72 h at higher concentration |
Genotoxicity | |||||
THP-1 | DON 0.1–10 μM ZEN 2–100 μM |
48 h | Antagonistic | Cell viability | DON + ZEN + 2 μM 0.8 + 16 μM 2 + 40 μM 4 + 80 μM 10 + 100 μM |
[117] |
ANA-1 | DON 0–33.7 µM ZEN 0–37.7 µM |
24 h | Synergistic | Cell viability and apoptosis | DON + ZEN concentration used for apoptosis and metabolism study 0.34 + 25.1 µM |
[118] |
Antagonistic | Cell metabolism | |||||
BF-2 | DON 0–16.2 µM ZEN 0–120.3 µM | 48 h | Antagonism | Cell viability fish Oxidative stress fish |
DON + ZEN 0.13 + 1.33 0.25 + 2.66 0.51 + 5.32 1.01 + 10.64 2.02 + 21.29 4.05 + 42.58 8.1 + 85.15 16.2 + 170.3 |
[119] |
Caco-2, HepaRG and THP-1 Co-culture |
DON + ZEN Concentration used when Caco-2 cells were in luminal compartment: 1.6 + 24 µM 3 + 31 µM Concentration used when HepaRG cells were in luminal compartment: +20 µM 2.3 + 33 µM |
48 h | No cytotoxicity with low concentration and in tri-culture Synergistic effect with higher concentration in bi-culture system |
Cell viability | [120] | |
Animal used | Toxin levels | Exposure time and route | Conclusions | Observations | Comment | References |
Zebrafish larvae | DON 67.5 µM ZEN 6.28 µM | 72 h | Antagonistic | Cell mortality | [119] | |
Mice | DON 1500, 2500 µg/kg bodyweight ZEN 20,000, 30,000 µg/kg bodyweight |
12 days Intraperitoneal injection |
Antagonistic | Oxidative stress Renal apoptosis |
DON + ZEN 1500 + 20,000 1500 + 30,000 2500 + 20,000 25 + 30,000 µg/kg bodyweight |
[121] |
Mice | DON 5000 µg/kg bodyweight ZEN 5000 µg/kg bodyweight |
2 weeks Oral administration |
Antagonistic | Oxidative stress | No change observed on liver weight | [111] |
Synergistic | Apoptosis | |||||
Rats | DON 30 µg/animal/day ZEN 15 µg/animal/day |
14 days Administered as a gavage dose |
Antagonistic | Liver weight Glutathione level in liver Malondialdehyde level in kidney |
Doses are according to EU limits in finished feed for young pigs | [122] |
Mice | DON 0.5–2 μM ZEN 10–40 μM |
24 h | Synergistic | Cell viability Immune function |
DON and ZEN combined 1:20 | [123] |
Rats | DON 16.5 µg/animal/day ZEN 12.75 µg/animal/day |
5 days Intraperitoneal administration |
Synergistic | Glutathione and glutathione peroxidase activity in the liver | Doses correspond to 1 mg/kg diet for DON and 1.5 mg/kg diet for ZEN which are close to EU limits in finished feed for young pigs | [124] |
Mice | DON 2000 mg/kg ZEN 20,000 mg/kg |
21 days Intragastric administration |
Antagonistic | Metabolic profiling of liver and serum | [125] | |
Mice | DON 2000 mg/kg ZEN 20,000 mg/kg |
3 weeks Intragastric administration |
Antagonistic | Metabolic pathway | [126] | |
Mice | DON 1500, 2500 µg/kg body weight ZEN 20,000, 30,000 µg/kg body weight |
4 days Intraperitoneal injection |
Synergistic | Apoptosis Antioxidant levels |
DON + ZEN 1500 + 20,000 1500 + 30,000 2500 + 20,000 2500 + 30,000 |
[127] |
Female piglets | DON 1000.6 µg/kg ZEN 269.1 µg/kg DON + ZEN 1007.5 + 265.4 µg/kg | 3 weeks Ad libitum feeding |
Synergistic | Body weight gain Average daily feed intake Intestinal functions |
Barley naturally contaminated with DON and corn naturally contaminated with ZEN was used to manufacture the feed | [128] |